Autograft beats mitomycin C for pterygium recurrence; 0.04% atropine slows myopia most; retinal occlusion patients get less brain imaging

A phoropter hanging from a short arm, its wide housing set with rows of small blank dials around two round lens openings.

Conjunctival autograft produced the lowest 12-month recurrence after pterygium surgery, 5.0%, versus 13.7% with mitomycin C and 22.9% with amniotic membrane, in a 750-patient randomized trial in JAMA Ophthalmology.

In children with myopia and intermittent exotropia, 0.04% atropine slowed progression more than lower doses. Patients with retinal artery occlusion got brain imaging less often than matched patients with transient ischemic attack.

The weekly innovation roundup for ophthalmology, published every Sunday for the week before; every item links to its sources. Latest ophthalmology news · All specialties

Latest news

Tagged ophthalmology, from the daily briefing

  1. Atropine 0.04% slowed myopia progression more than 0.01% or 0.02% in 264 children with intermittent exotropia
  2. Trial of 750 adults compares amniotic membrane, conjunctival autograft and mitomycin C to prevent pterygium recurrence
  3. Two public glaucoma datasets used to validate AI share at least 1,031 identical eye scans, inflating reported accuracy

See all the latest news